Patent 9789204 was granted and assigned to Immunogen, Inc. on October, 2017 by the United States Patent and Trademark Office.
The invention provides a process for preparing a cell-binding agent chemically coupled to a drug. The process comprises covalently attaching a linker to a cell-binding agent, a purification step, conjugating a drug to the cell-binding agent and a subsequent purification step.